These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Lee N, Wong CK, Chan PK, Lun SW, Lui G, Wong B, Hui DS, Lam CW, Cockram CS, Choi KW, Yeung AC, Tang JW, Sung JJ. Clin Infect Dis; 2007 Sep 15; 45(6):723-31. PubMed ID: 17712756 [Abstract] [Full Text] [Related]
9. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. Klimiuk PA, Sierakowski S, Latosiewicz R, Skowronski J, Cylwik JP, Cylwik B, Chwiecko J. J Rheumatol; 2005 Sep 15; 32(9):1666-72. PubMed ID: 16142858 [Abstract] [Full Text] [Related]
10. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. Dajotoy T, Andersson P, Bjartell A, Löfdahl CG, Tapper H, Egesten A. J Leukoc Biol; 2004 Sep 15; 76(3):685-91. PubMed ID: 15197236 [Abstract] [Full Text] [Related]
11. Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Greenberg SA, Higgs BW, Morehouse C, Walsh RJ, Kong SW, Brohawn P, Zhu W, Amato A, Salajegheh M, White B, Kiener PA, Jallal B, Yao Y. Genes Immun; 2012 Apr 15; 13(3):207-13. PubMed ID: 21881594 [Abstract] [Full Text] [Related]
12. Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis. Morimoto S, Tokano Y, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Suzuki J, Kaneko H, Sekigawa I, Takasaki Y. Autoimmunity; 2009 Feb 15; 42(2):143-9. PubMed ID: 19021013 [Abstract] [Full Text] [Related]
14. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y. Ann Rheum Dis; 2011 Nov 15; 70(11):2029-36. PubMed ID: 21803750 [Abstract] [Full Text] [Related]
15. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis. Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G, Hochgesand S, Nessler S, Rothhammer V, Lang M, Hartung HP, Hemmer B. Arch Neurol; 2009 Oct 15; 66(10):1216-23. PubMed ID: 19667211 [Abstract] [Full Text] [Related]
16. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis. Huard C, Gullà SV, Bennett DV, Coyle AJ, Vleugels RA, Greenberg SA. Br J Dermatol; 2017 May 15; 176(5):1224-1230. PubMed ID: 27564228 [Abstract] [Full Text] [Related]
18. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, Szeto CC. Nephrol Dial Transplant; 2006 Jun 15; 21(6):1534-40. PubMed ID: 16449281 [Abstract] [Full Text] [Related]
19. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A. J Rheumatol; 1999 Feb 15; 26(2):425-31. PubMed ID: 9972980 [Abstract] [Full Text] [Related]